59 related articles for article (PubMed ID: 6846614)
1. Opacities and thioridazine.
Westlin WF
Am J Psychiatry; 1983 May; 140(5):658-9. PubMed ID: 6846614
[No Abstract] [Full Text] [Related]
2. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
Gualtieri CT; Lefler WH; Guimond M; Staye JI
Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
[TBL] [Abstract][Full Text] [Related]
3. Phenothiazines in ophthalmology.
Siddall JR
Int Ophthalmol Clin; 1967; 7(1):207-15. PubMed ID: 5599926
[No Abstract] [Full Text] [Related]
4. Priapism associated with thiothixene, chlorpromazine, and thioridazine.
Balon R; Berchou R; Han H
J Clin Psychiatry; 1987 May; 48(5):216. PubMed ID: 3571177
[No Abstract] [Full Text] [Related]
5. Long term evolution of the side-effect lens opacities induced by chlorpromazine prolonged therapy.
Baron JB; Rivoalan Y; Morel P
Agressologie; 1971; 12(1):57-60. PubMed ID: 5088348
[No Abstract] [Full Text] [Related]
6. [Hemodynamic risks in phenothiazine medication].
Carlsson C; Dencker S; Grimby G; Häggendal J
Lakartidningen; 1967 May; 64(19):1906. PubMed ID: 6043969
[No Abstract] [Full Text] [Related]
7. Deposits in the lens and cornea of the eye during long-term chlorpromazine medication.
Rasmussen K; Kirk L; Faurbye A
Acta Psychiatr Scand; 1976 Jan; 53(1):1-6. PubMed ID: 1251751
[TBL] [Abstract][Full Text] [Related]
8. Single phenothiazines and tardive dyskinesia.
Yassa R; Dimitry R
J Clin Psychiatry; 1983 Jun; 44(6):233-4. PubMed ID: 6853464
[No Abstract] [Full Text] [Related]
9. Total dosage of chlorpromazine and ocular opacities.
Buffaloe WJ; Johnson AW; Sandifer MG
Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587
[No Abstract] [Full Text] [Related]
10. Deep-vein thrombosis with antipsychotic drugs.
Varia I; Krishnan RR; Davidson J
Psychosomatics; 1983 Dec; 24(12):1097-8. PubMed ID: 6665117
[No Abstract] [Full Text] [Related]
11. Agents which cause pigmentary retinopathy.
Potts AM
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:16-8. PubMed ID: 5672558
[No Abstract] [Full Text] [Related]
12. Neuroleptic withdrawal behavior--cases of rebound cholinergic supersensitivity.
Inoue F
Clin Pharm; 1982; 1(6):567-9. PubMed ID: 7185550
[No Abstract] [Full Text] [Related]
13. Withdrawal akinesia.
Inoue F; Janikowski AM
J Neurol Neurosurg Psychiatry; 1981 Oct; 44(10):958. PubMed ID: 7310414
[No Abstract] [Full Text] [Related]
14. Electrocardiographic changes induced by phenothiazine drugs.
Ban TA; St Jean A
Am Heart J; 1965 Oct; 70(4):575-6. PubMed ID: 5834204
[No Abstract] [Full Text] [Related]
15. Adynamic ileus during psychoactive medication: a report of three fatal and five severe cases.
Warnes H; Lehmann HE; Ban TA
Can Med Assoc J; 1967 Apr; 96(15):1112-3. PubMed ID: 6021058
[No Abstract] [Full Text] [Related]
16. [Ocular changes in chlorpromazine-induced melanosis].
Schönthaler M
Klin Oczna; 1984 Nov; 86(11):491-2. PubMed ID: 6535884
[No Abstract] [Full Text] [Related]
17. Antiparkinson drug overuse.
DiMascio A; Demirgian E
Psychosomatics; 1970; 11(6):596-601. PubMed ID: 5496192
[No Abstract] [Full Text] [Related]
18. [Iatrogenic cataract].
Koch HR; Hockwin O
Ther Ggw; 1975 Sep; 114(9):1450-62. PubMed ID: 1188698
[No Abstract] [Full Text] [Related]
19. Mania-induced remission of tardive dyskinesia in manic-depressive illness.
Weiner WJ; Werner TR
Ann Neurol; 1982 Aug; 12(2):229-30. PubMed ID: 7125612
[No Abstract] [Full Text] [Related]
20. Improvement of both tardive dystonia and akathisia after botulinum toxin injection.
Shulman LM; Singer C; Weiner WJ
Neurology; 1996 Mar; 46(3):844-5. PubMed ID: 8618701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
